MeSH Review:
Glomerulonephritis
- IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Gharavi, A.G., Yan, Y., Scolari, F., Schena, F.P., Frasca, G.M., Ghiggeri, G.M., Cooper, K., Amoroso, A., Viola, B.F., Battini, G., Caridi, G., Canova, C., Farhi, A., Subramanian, V., Nelson-Williams, C., Woodford, S., Julian, B.A., Wyatt, R.J., Lifton, R.P. Nat. Genet. (2000)
- Mutation of DNASE1 in people with systemic lupus erythematosus. Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., Kuroda, Y. Nat. Genet. (2001)
- Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. Rao, T.K., Filippone, E.J., Nicastri, A.D., Landesman, S.H., Frank, E., Chen, C.K., Friedman, E.A. N. Engl. J. Med. (1984)
- Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Hibbs, M.L., Tarlinton, D.M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., Stacker, S.A., Dunn, A.R. Cell (1995)
- Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Isaka, Y., Brees, D.K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N.A., Border, W.A. Nat. Med. (1996)
- Microcephaly, focal segmental glomerulonephritis and marfanoid habitus in two sibs. Houlston, R.S., Iraggori, S., Murday, V., Scrine, M., Macdermot, K., Slack, J., Rees, L. Clin. Dysmorphol. (1992)
- Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Botto, M., Dell'Agnola, C., Bygrave, A.E., Thompson, E.M., Cook, H.T., Petry, F., Loos, M., Pandolfi, P.P., Walport, M.J. Nat. Genet. (1998)
- Beneficial effects of prostaglandin E1 in rapidly progressive glomerulonephritis. Niwa, T., Maeda, K., Asada, H., Yamamoto, M., Yamada, K. N. Engl. J. Med. (1983)
- Studies of immune-complex glomerulonephritis mediated by human thyroglobulin. Jordan, S.C., Buckingham, B., Sakai, R., Olson, D. N. Engl. J. Med. (1981)
- Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Border, W.A., Noble, N.A., Yamamoto, T., Harper, J.R., Yamaguchi, Y., Pierschbacher, M.D., Ruoslahti, E. Nature (1992)
- Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Raychowdhury, R., Niles, J.L., McCluskey, R.T., Smith, J.A. Science (1989)
- Relapsing polychondritis with glomerulonephritis. Improvement with prednisone and cyclophosphamide. Ruhlen, J.L., Huston, K.A., Wood, W.G. JAMA (1981)
- Plasmapheresis for rapidly progressive glomerulonephritis: the mystique of dramatic intervention. Friedman, E.A. JAMA (1980)
- Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase. Gigli, I., Sorvillo, J., Mecarelli-Halbwachs, L., Leibowitch, J. J. Exp. Med. (1981)
- Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan. Fillit, H., Damle, S.P., Gregory, J.D., Volin, C., Poon-King, T., Zabriskie, J. J. Exp. Med. (1985)
- Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. Johnson, R.J., Raines, E.W., Floege, J., Yoshimura, A., Pritzl, P., Alpers, C., Ross, R. J. Exp. Med. (1992)
- Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. Li, S., Kurts, C., Köntgen, F., Holdsworth, S.R., Tipping, P.G. J. Exp. Med. (1998)
- Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. Santiago, M.L., Fossati, L., Jacquet, C., Müller, W., Izui, S., Reininger, L. J. Exp. Med. (1997)
- Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist. Pippin, J.W., Qu, Q., Meijer, L., Shankland, S.J. J. Clin. Invest. (1997)
- Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus. Cole, E.H., Schulman, J., Urowitz, M., Keystone, E., Williams, C., Levy, G.A. J. Clin. Invest. (1985)
- Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane. Kerjaschki, D., Miettinen, A., Farquhar, M.G. J. Exp. Med. (1987)
- Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice. Wang, J., Koizumi, T., Watanabe, T. J. Exp. Med. (1996)
- Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells. Lovett, D.H., Larsen, A. J. Clin. Invest. (1988)
- Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. Feng, L., Xia, Y., Yoshimura, T., Wilson, C.B. J. Clin. Invest. (1995)
- Features of systemic lupus erythematosus in Dnase1-deficient mice. Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H.G., Möröy, T. Nat. Genet. (2000)
- Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Nishimura, H., Nose, M., Hiai, H., Minato, N., Honjo, T. Immunity (1999)
- Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. Kitching, A.R., Holdsworth, S.R., Ploplis, V.A., Plow, E.F., Collen, D., Carmeliet, P., Tipping, P.G. J. Exp. Med. (1997)
- Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. Balomenos, D., Rumold, R., Theofilopoulos, A.N. J. Clin. Invest. (1998)
- A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. Huang, Y., Haraguchi, M., Lawrence, D.A., Border, W.A., Yu, L., Noble, N.A. J. Clin. Invest. (2003)
- Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Border, W.A., Okuda, S., Languino, L.R., Sporn, M.B., Ruoslahti, E. Nature (1990)
- Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. Roubinian, J.R., Talal, N., Greenspan, J.S., Goodman, J.R., Siiteri, P.K. J. Exp. Med. (1978)
- The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. Weinberg, J.B., Granger, D.L., Pisetsky, D.S., Seldin, M.F., Misukonis, M.A., Mason, S.N., Pippen, A.M., Ruiz, P., Wood, E.R., Gilkeson, G.S. J. Exp. Med. (1994)
- Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. Yung, R., Powers, D., Johnson, K., Amento, E., Carr, D., Laing, T., Yang, J., Chang, S., Hemati, N., Richardson, B. J. Clin. Invest. (1996)
- Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1 beta-stimulated rat mesangial cells. Mühl, H., Pfeilschifter, J. J. Clin. Invest. (1995)